Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Approved programs Pipeline Programs

ClinicalTrials.gov programs marked approved or launched in registry data.

Programs 1,839
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.

Top sponsors

Pipeline programs

Page 37 of 39

  1. low-dose rivaroxaban

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Atrial Fibrillation

    approved small molecule active

    1 trial

  2. low-dose tenecteplase intravenous thrombolysis

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Ischemic Stroke Patients

    approved small molecule active

    1 trial

  3. low-dose ticagrelor

    The First People's Hospital of Lianyungang

    Platelet Reactivity

    approved small molecule completed

    1 trial

  4. low-dose ticagrelor

    The First People's Hospital of Lianyungang

    Coronary Artery Disease

    approved small molecule active

    1 trial

  5. lubiprostone

    Takeda

    Chronic Idiopathic Constipation

    approved small molecule completed

    3 trials

  6. lubiprostone

    Takeda

    Healthy

    approved small molecule completed

    1 trial

  7. lubiprostone (Amitiza)

    Takeda

    Colonoscopy

    approved small molecule completed

    1 trial

  8. mebeverine

    United Therapeutics Europe Ltd

    Irritable Bowel Syndrome

    approved small molecule completed

    1 trial

  9. medication for opioid use disorder

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    approved small molecule completed

    1 trial

  10. melphalan hydrochloride for injection

    CASI Pharmaceuticals

    Multiple Myeloma

    approved small molecule active

    2 trials

  11. mesenchymal stromal cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    MSC

    approved mab active

    1 trial

  12. metformin

    Boehringer Ingelheim

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial

  13. methadone

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Dependence

    approved small molecule completed

    1 trial

  14. methotrexate (MTX)

    AbbVie

    Psoriatic Arthritis

    approved small molecule completed

    1 trial

  15. methoxy polyethylene glycol-epoetin beta [Mircera]

    Hoffmann-La Roche

    Anemia

    approved small molecule terminated

    2 trials

  16. midazolam

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Mechanical Ventilation

    approved small molecule active

    1 trial

  17. midodrine hydrochloride (ProAmatine®)

    Takeda

    Hypotension, Orthostatic

    approved small molecule terminated

    1 trial

  18. miglustat

    Ultragenyx UK Limited

    GM1 Gangliosidoses

    approved small molecule terminated

    1 trial

  19. minimally invasive cholecystolithotomy with gallbladder reservation

    The First People's Hospital of Lianyungang

    Gallstones

    approved other active

    1 trial

  20. mirabegron

    Hospital Authority, Hong Kong

    Sjogren's Syndrome

    approved small molecule active

    1 trial

  21. mirabegron

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sjogren's Syndrome

    approved small molecule active

    1 trial

  22. morphine

    United Therapeutics Europe Ltd

    Cardiovascular Disease

    approved small molecule completed

    1 trial

  23. morphine sulfate

    Pacira Ireland Limited

    Bowel Obstruction

    approved small molecule terminated

    1 trial

  24. mouse nerve growth factor

    The First People's Hospital of Lianyungang

    Cerebral Small Vessel Diseases

    approved small molecule active

    1 trial

  25. moxifloxacin

    Hospital Authority, Hong Kong

    Intra-abdominal Infection

    approved small molecule completed

    1 trial

  26. mycophenolate mofetil

    United Therapeutics Europe Ltd

    IGA Nephropathy

    approved small molecule completed

    1 trial

  27. mycophenolate mofetil (Myfenax)

    Teva Pharma GmbH

    Stable Renal Transplant Recipients

    approved small molecule terminated

    1 trial

  28. naltrexone for extended release injectable suspension

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved small molecule completed

    1 trial

  29. neoadjuvant therapy

    The First People's Hospital of Lianyungang

    Hepatocellular Carcinoma Resectable

    approved other active

    1 trial

  30. nicorandil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    STEMI - ST-segment Elevation Myocardial Infarction

    approved small molecule active

    1 trial

  31. nicotine patch

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Dependence

    approved small molecule completed

    2 trials

  32. omeprazole plus amoxicillin

    Hospital Authority, Hong Kong

    Duodenal Ulcer

    approved small molecule completed

    1 trial

  33. oral entecavir 0.5mg daily and adefovir 10mg daily for 144 weeks

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Hepatitis B

    approved small molecule active

    1 trial

  34. pegylated interferon alpha and plus ribavirin

    Hospital Authority, Hong Kong

    Chronic Hepatitis C

    approved small molecule completed

    1 trial

  35. phacoemulsification

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Astigmatism

    approved other active

    1 trial

  36. physiotherapeutic treatment

    Universal Integrated

    Morquio's Disease

    approved other terminated

    1 trial

  37. pioglitazone

    GlaxoSmithKline

    Diabetes Mellitus, Type 2

    approved small molecule terminated

    1 trial

  38. pioglitazone

    Takeda

    Type 2 Diabetes Mellitus

    approved small molecule completed

    4 trials

  39. pioglitazone

    Takeda

    Type 2 Diabetes

    approved small molecule completed

    1 trial

  40. placebo

    Shandong University

    Sedation

    approved small molecule active

    1 trial

  41. placebo

    Takeda

    Constipation

    approved small molecule completed

    1 trial

  42. pregabalin

    Pfizer

    Diabetic Neuropathy, Painful

    approved small molecule completed

    1 trial

  43. pregabalin and celecoxib

    Pfizer

    Chronic Low Back Pain With a Neuropathic Component

    approved small molecule terminated

    1 trial

  44. premeal insulin lispro mixtures

    Eli Lilly and Company

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial

  45. preoperative 0.5% ropivacaine hydrochloride preoperative

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Postoperative Pain

    approved small molecule completed

    1 trial

  46. prescribing anapproved drug, examination

    The First People's Hospital of Lianyungang

    Irritable Bowel Syndrome With Diarrhea

    approved small molecule active

    1 trial

  47. primaquine

    Repatha

    Malaria, Vivax

    approved small molecule terminated

    1 trial

  48. profound neuromuscular blockade

    The First People's Hospital of Lianyungang

    Profound Muscle Relaxation

    approved small molecule active

    1 trial

Frequently asked questions

How many Approved programs pipeline programs are in the directory?

1,839 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.